Protherics PLC (LON:PTI) to Release Preliminary 2007 Earnings June 3

Protherics PLC (LON:PTI) will release the preliminary earnings for 2007 on Tuesday, June 3.  The financial results will be made available on the Investors section of the company’s website at protherics.co.uk/Financials/calendar_and_reports.aspx.

Protherics PLC is a United Kingdom-based biopharmaceutical company focused on critical care and cancer.

The Company is organized into two business segments: the sale, manufacture and development of pharmaceutical products, and royalties arising from out-licensed technology. Its operations are located in the United Kingdom, United States and Australia.

On January 3, 2007, the Company acquired 100% of the issued share capital of MacroMed Inc. (subsequently renamed Protherics Salt Lake City Inc.), a private United States Company, to access its principal product OncoGel, a sustained release formulation of Paclitaxel for local administration in oesophageal and brain cancers. Some of the other products of the Company include CroFab, DigiFab, Digoxin Immune Fab, CytoFab, Voraxaze, OncoGel, Prolarix, Acadesine and Angiotensin Therapeutic Vaccine.

Find more Earnings events on Finditt Events.